Virtual, Personalized Care Powered by Clinically Meaningful Intelligence.


OUR TECHNOLOGY
EMU™ extends epilepsy monitoring beyond the traditional hospital-based Epilepsy Monitoring Unit (EMU) into patients’ daily lives by integrating longitudinal, real-world data from wearables, ambulatory EEG, implantable devices, and patient-reported outcomes. Powered by Neuroliten™, it delivers clinically meaningful intelligence that enables personalized treatment decisions, scalable remote monitoring, earlier intervention, and expanded access to specialty epilepsy care—including rural and underserved populations.
Learn moreHOW IT WORKS
vEMU keeps neurologists connected to their patients between visits—turning real-world data into earlier, better-informed treatment decisions.

COMPLEMENTARY, NOT COMPETING
| Feature | Traditional EMU | vEMU (Virtual EMU) |
|---|---|---|
| Care Setting | Inpatient, hospital-based | At home, in the real world |
| Monitoring Duration | Typically 3–7 days | Days to months (as needed) |
| Cost | High ($10K–$25K per admission) | Up to 60–80% lower |
| Patient Experience | Disruptive, hospital stay | Comfortable, convenient |
| Seizure Capture | Limited to admission window | Higher yield over time |
| Data Depth | EEG only (limited context) | Multi-modal (EEG, ECG, activity, sleep, adherence, PROs) |
| Access to Care | Limited by bed availability | Scalable and widely accessible |
| Clinical Impact | Reactive | Proactive, continuous, personalized |
Rather than replacing the traditional EMU, EMU™ complements it by extending continuous monitoring beyond hospital walls, helping clinicians make earlier, more informed decisions about medications, surgery, and advanced therapies.
THE BIGGER PICTURE
vEMU connects patients, neurologists, hospitals, pharma, payers, and clinical researchers into one continuous, AI-powered loop—built around better health outcomes.

Neuroliten is a Digital Thalamusfor neurology care – a relay for multimodal information & insights
Ashutosh Raina, MDNeuroliten’s vEMU complements a traditional EMU and enhances its capacity utilization
Prof. Paul Garcia, MDNeuroliten’s vEMU screens patients for traditional EMU & for surgical/neuromodulation procedures
Prof. Neggy Rismanchi MD, PhDNeuroliten’s vEMU expands access to rural and underserved populations
Prof. Sean Pauzauskie, MD